Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy
Our prediction model, which integrated data from preoperative positron emission tomography-CT, preoperative blood parameters and pathological response, was able to make highly accurate predictions for disease-free and overall survival in patients with NSCLC receiving neoadjuvant immunity with chemical therapy.
Authors
- Zhenfa Zhang (ORCID: https://orcid.org/0000-0002-9627-2590)
- Mengzhe Zhang (ORCID: https://orcid.org/0000-0003-0682-1574)
- Zengtuan Xiao (ORCID: https://orcid.org/0000-0003-0667-2353)
- Xiaofei Wang (ORCID: https://orcid.org/0000-0001-7731-0339)
- Yue Li (ORCID: https://orcid.org/0000-0003-3747-1482)
- Pengpeng Zhang (ORCID: https://orcid.org/0000-0003-1488-265X)
- Yan Meng (ORCID: https://orcid.org/0009-0001-4398-0243)
- Liu Zuo
- Lianmin Zhang (ORCID: https://orcid.org/0000-0002-7419-9628)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1093/ejcts/ezae335
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.84